| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Poisoning by lidocaine |
Causative agent (attribute) |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine measurement |
Component |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
| Accidental lignocaine poisoning |
Causative agent (attribute) |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Intentional lignocaine poisoning (disorder) |
Causative agent (attribute) |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lignocaine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
| Lignocaine adverse reaction (disorder) |
Causative agent (attribute) |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to lidocaine (finding) |
Causative agent (attribute) |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine overdose |
Causative agent (attribute) |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
| Accidental lignocaine overdose (disorder) |
Causative agent (attribute) |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
| Intentional lignocaine overdose (disorder) |
Causative agent (attribute) |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
| Lignocaine overdose of undetermined intent |
Causative agent (attribute) |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
| Lignocaine hydrochloride [antiarrhythmic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lignocaine hydrochloride [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine+prilocaine 2.5%/2.5% cream+occlusive dressing |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lignocaine HCl [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lignocaine [generic addit] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 100mg/10mL(1%) prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2% dental cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 100mg/5mL(2%) prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+epinephrine 0.5%/1:200,000 injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 5 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 10 mg/mL cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine hydrochloride 50 milligram/1 gram conventional release gingival ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine 10 mg/actuation oromucosal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+epinephrine 2%/1:80,000 cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+fluorescein sodium 4%/0.25% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing epinephrine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing chlorhexidine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing fluorescein stain and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing glucose and lidocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing lidocaine and prilocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
| Lidocaine 1.5% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+chlorhexidine 1%/0.25% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+chlorhexidine 2%/0.25% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 0.1%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 0.2%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 0.4%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 0.6%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 1% injection solution sterile ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2% injection solution sterile ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 4% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride heavy 5% injection solution sterile ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 0.5% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 1% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 1% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+epinephrine 4% preservative free nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+glucose 0.2%/5% Polyfusor |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride+glucose 0.4%/5% Polyfusor |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 40mg/mL(4%) sterile solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| IV Lidocaine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Local lidocaine injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing lidocaine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 1%/epinephrine 1:200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2%/epinephrine 1:200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing lidocaine and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
| Lidocaine hydrochloride 1.5%/epinephrine 1:200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2%/epinephrine 1:500,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 2%/epinephrine 1:100,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 100mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine 46.1mg/unt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 12mg/dose spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine 50 microgram/mg cutaneous patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 1.5% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 0.5% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 40mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 4% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine 5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrocarbonate 10mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Dextrose + lidocaine hydrochloride 75mg/50mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Epinephrine 10mcg/lidocaine hydrochloride 20mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Epinephrine 20mcg/lidocaine hydrochloride 20mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Epinephrine 10mcg/lidocaine hydrochloride 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Epinephrine + lidocaine hydrochloride 10mcg/20mg injecti |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Epinephrine + lidocaine hydrochloride 20mcg/20mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Epinephrine 5mcg/lidocaine hydrochloride 15mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate 5mcg/lidocaine hydrochloride 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + lidocaine hydrochloride 10mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + lidocaine hydrochloride 20mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine + prilocaine 25mg/25mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 5%/glucose 7.5% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 1%/epinephrine 1:100,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Dextrose 7.5%ww/lidocaine hydrochloride 1.5%ww injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
1 |
| acétate de méthylprednisolone et chlorhydrate de lidocaïne 80/20 mg/2 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| acétate de méthylprednisolone et chlorhydrate de lidocaïne 40/10 mg/1 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing lidocaine and methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
| Oxytetracycline+lidocaine 50mg/mL/2% injection 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Oxytetracycline+lidocaine 50mg/mL/2% injection 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Oxytetracycline+lidocaine 125mg/mL/2% injection 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
| Product containing lidocaine and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lidocaine (substance) |
Inferred relationship |
Some |
2 |
| Domiphen bromide+lidocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lidocaine (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]